<p>Shandong Boan Biotechnology Co. Ltd. has announced that its controlling shareholder, Luye Pharma Group Ltd., through its wholly-owned subsidiary Shandong Luye Pharmaceutical Co., Ltd., will transfer 11,986,600 H shares of Boan Biotechnology to the Issuer on 27 January 2026. This transfer is part of the completion of a previously announced proposed transfer, in accordance with the terms of a subscription agreement related to Exchangeable Preference Shares. The board of Boan Biotechnology does not expect the transaction to have any material adverse effect on the group’s business operations. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260126-12001549), on January 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

<p>Shandong Boan Biotechnology Co. Ltd. will transfer 11,986,600 H shares to the Issuer on January 27, 2026, as part of a minority stake deal initiated by its controlling shareholder, Luye Pharma Group Ltd. The board expects no material adverse effects on the company's operations from this transaction. This announcement follows a subscription agreement related to Exchangeable Preference Shares.</p>

Reuters

Founder Fubon CSI Medicine and Medical Device Innovation ETF

E Fund CSI 300 Health Care ETF

Guotai CSI Bio-medicine ETF

Tianhong CNI BIOMEDICINE ETF

BOAN BIOTECH

E Fund Hang Seng SCHK Innovative Drug ETF

China Southern Hang Seng Biotech ETF(QDII)

GF CSI HK Innovative Drugs Industry ETF(QDII)

ChinaAMC SSE Health Care ETF Initiating Fund

Penghua SSE STAR Biology and Medicine ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

ChinaAMC CSI Biotechnology Theme ETF

Ping An CSI Medicine and Medical Device Innovation ETF

E Fund CSI Biotechnology Theme ETF

LUYE PHARMA

China Merchants CSI Biotechnology Theme ETF

Bosera Hang Seng Health Care ETF(QDII)

Yinhua CSI Innovative Drugs Industry ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Huaan Hang Seng Biotech ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Penghua CSI HK Connect Health Care Composite ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Minsheng Royal CSI Biotechnology Theme ETF

Yinhua CSI Research Sector 100 ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Shandong Boan Biotechnology Transfers 11.99 Million H Shares to Complete Minority Stake Deal